Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate-specific antigen: current status.

M Lukes1, M Urban, M Záleský

  • 1Clinics of Urology, 3rd Medical Faculty, Charles University, Prague, Czech Republic.

Folia Biologica
|April 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.

Stem cell research & therapy·2025
Same author

Endocrine Disruptors and Estrogens in Human Prostatic Tissue.

Physiological research·2023
Same author

Measurement of polarization observables <math></math>, <math></math>, and <math></math> in <math></math> and <math></math> photoproduction off quasi-free nucleons.

The European physical journal. A, Hadrons and nuclei·2023
Same author

[Pathological Lesions and Fractures of the Proximal Femur].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca·2023
Same author

Making a difference in the real world. User-centred impact evaluation of an eight-country, community-based early childhood programme.

Evaluation and program planning·2022
Same author

Impact Ionization Induced by Terahertz Radiation in HgTe Quantum Wells of Critical Thickness.

Journal of infrared, millimeter and terahertz waves·2021
Same journal

MiR-335-3p Alleviates Adipogenesis and Inflammation in Bone Marrow-Derived Mesenchymal Stem Cells in Osteoporotic Fractures.

Folia biologica·2026
Same journal

Research on the Diagnostic Potential of miR-383-5p in Rheumatoid Arthritis.

Folia biologica·2026
Same journal

The Predictive Value of NLRP3-Mediated Inflammatory Factor Production for Abnormal Liver Function in Pregnant Women with Hepatitis B.

Folia biologica·2026
Same journal

Mechanism Study and Analysis of Correlation between miR-409-3p and Post-Stroke Cognitive Impairment.

Folia biologica·2026
Same journal

Correlation between circ_0092576 and Arterial Stenosis Severity and Inflammatory Status in Patients with Coronary Heart Disease and Its Clinical Value.

Folia biologica·2026
Same journal

Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis.

Folia biologica·2026
See all related articles

Prostate-Specific Antigen (PSA) is crucial for managing prostate disease and early cancer detection. New methods aim to improve PSA test accuracy, addressing limitations in the diagnostic gray zone for better prostate cancer identification.

Area of Science:

  • Urology
  • Oncology
  • Biochemistry

Background:

  • Prostate-Specific Antigen (PSA) is a vital tumor marker in managing male prostatic diseases.
  • Early detection of prostate cancer, a common neoplasm, heavily relies on PSA.
  • Current PSA screening faces challenges, particularly low specificity in the 4-10 ng/ml range.

Purpose of the Study:

  • To review the molecular forms and characteristics of PSA.
  • To discuss factors affecting serum PSA concentrations and screening issues.
  • To evaluate methods for enhancing PSA test sensitivity and specificity in prostate cancer detection.

Main Methods:

  • Analysis of PSA molecular forms and influencing factors.
  • Evaluation of diagnostic gray zone limitations (4-10 ng/ml).

Related Experiment Videos

  • Assessment of advanced detection techniques: PSA density, transition zone PSA density, PSA velocity, PSA doubling time, age-specific PSA, free PSA, and RT-PCR.

    • Main Results:

    • PSA is essential for prostate cancer management and early detection.
    • Low specificity of PSA in the 4-10 ng/ml range presents a diagnostic challenge.
    • Various methods show potential to improve PSA test accuracy.

    Conclusions:

    • PSA remains a cornerstone in prostate cancer diagnostics.
    • Improving PSA specificity is critical for accurate diagnosis.
    • Advanced techniques offer promising avenues for more precise prostate cancer detection.